UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000008024 |
|---|---|
| Receipt number | R000009438 |
| Scientific Title | Phase II clinical trial of combination chemotherapy with bendamustine and rituximab for relapsed or refractory CD20 positive indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma patients |
| Date of disclosure of the study information | 2012/06/04 |
| Last modified on | 2016/11/26 15:15:54 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/05/24 18:14:26 | ||
| 2 | Update | 2012/07/26 08:23:45 | Recruitment status Anticipated trial start date |
|
| 3 | Update | 2012/07/26 08:28:25 | Research ethics review |
|
| 4 | Update | 2013/12/22 14:40:11 | Email |
|
| 5 | Update | 2014/04/10 16:39:25 | Recruitment status |
|
| 6 | Update | 2016/11/26 15:14:55 | Key inclusion criteria |
|
| 7 | Update | 2016/11/26 15:15:54 | Name of primary person or sponsor Organization |
